Digital Health Global

MARCH 2, 2023

As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development.

Life Science 88

Life Science Drug Development BioTech Leadership 88

Healthcare IT Today

NOVEMBER 6, 2023

PicnicHealth , a patient-centered healthcare evidence generation company, today announced the acquisition of AllStripes , a platform dedicated to generating evidence about the rare disease community. The focus of the solutions will be making clinical research and registry development more effective and efficient.

Life Science 117

Life Science Drug Development Patient Experience healthcare technology 117

Lloyd Price

NOVEMBER 16, 2024

The new company aims to leverage its extensive data sets and technology to provide innovative solutions across various healthcare sectors, including life sciences, provider, imaging, health plan, employer, and government health and human services.

Drug Development 57

Drug Development healthcare technology Leadership Life Science 57

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. and Europe.

BioTech 88

BioTech Life Science Leadership Drug Development 88

Lloyd Price

FEBRUARY 18, 2024

AI and machine learning: Companies with advanced AI solutions for tasks like drug discovery, clinical trial optimisation, and personalised medicine can be attractive targets. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pharmaceuticals 67

Pharmaceuticals healthcare technology Digital Health Remote care 67

Healthcare IT Today

NOVEMBER 14, 2022

Mountain Group Partners is an investor dedicated to investing in and actively guiding transformational businesses in the Technology, Animal Health, and Life Sciences sectors. Technology investments focus on business and healthcare technology, targeting those ideas with quantifiable development risk and a rapid path to market.

Life Science 96

Life Science HIPAA Drug Development healthcare technology 96